Posner Christopher has filed 15 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 583 shares of Tvardi Therapeutics, Inc. ($TVRD) on February 28, 2025.
Activity breakdown: 0 open-market purchases and 13 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 583 | $4.75 | 13,109.0000 | 4,562,738 | 4.26% | 0.01% |
| Feb. 4, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 372 | $4.72 | 13,692.0000 | 4,562,738 | 2.65% | 0.01% |
| Nov. 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 3668 | $0.29 | 168,768.0000 | 2,574,767 | 2.13% | 0.14% |
| Aug. 1, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 4149 | $0.35 | 172,436.0000 | 2,574,767 | 2.35% | 0.16% |
| May 2, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 3936 | $0.75 | 176,585.0000 | 1,516,336 | 2.18% | 0.26% |
| Feb. 29, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 5834 | $0.89 | 180,521.0000 | 4,512,422 | 3.13% | 0.13% |
| Feb. 8, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 35575 | $0.53 | 186,355.0000 | 4,512,422 | 16.03% | 0.79% |
| Feb. 1, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | A | Common Stock | 62500 | $0.00 | 226,911.0000 | 4,512,422 | 38.01% | 1.39% |
| Feb. 1, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | PRESIDENT AND CEO | S | Common Stock | 4981 | $0.55 | 221,930.0000 | 4,512,422 | 2.20% | 0.11% |
| Nov. 2, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | S | Common Stock | 3796 | $1.22 | 164,411.0000 | 54,235,695 | 2.26% | 0.01% |
| Aug. 3, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | S | Common Stock | 4307 | $3.07 | 168,207.0000 | 54,002,988 | 2.50% | 0.01% |
| May 5, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | S | Common Stock | 3869 | $4.40 | 172,514.0000 | 53,872,038 | 2.19% | 0.01% |
| March 3, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | S | Common Stock | 5987 | $9.71 | 176,383.0000 | 4,471,130 | 3.28% | 0.13% |
| March 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 4,471,130 | 9999.99% | 5.59% |
| Feb. 2, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Posner Christopher | President and CEO | S | Common Stock | 4191 | $11.80 | 182,370.0000 | 4,471,130 | 2.25% | 0.09% |